Literature DB >> 6965897

Microcinematographic study on the effect of methotrexate upon mouse mammary tumor cells (MMT cell line).

Y Alvarez-Rodríguez, A Ruano, Y Valladares.   

Abstract

The effect of methotrexate (amethopterin) upon the MMT cell line was studied by time-lapse microcinematography, the plasma levels obtained after systemic administration of maximum tolerated doses of the drug in man being simulated in vitro. Cells in the logarithmic growth phase (large growth fraction population) were widely affected, although enough drug-resistant cells remained to regenerate the cell colony. Cells in the preconfluent growth phase (small growth fraction population) were less effected, because many cells were arrested at the GO-hase, outside the cell cycle. A drug-resistant colony always developed, making the drug therapy useless. The experiments showed that rescue treatment with leucovorin (citrovorum factor of folinic acid) was not effective either, because, at least on our experimental conditions, recovery of the mitotic activity was more rapid and the number of degenerating cells smaller with rescur treatment than with the conventional treatment. The results also suggested a new mechanism of methotrexate action in addition to the classic one of folic acid inhibition, which might consist in the inhibition of the production of formyl-methionyl-tRNA, part of the initiation complex in protein biosynthesis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6965897     DOI: 10.1007/BF00255460

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  4 in total

1.  Folic acid antagonists in cancer chemotherapy.

Authors:  L DELMONTE; T H JUKES
Journal:  Pharmacol Rev       Date:  1962-03       Impact factor: 25.468

2.  Eradication of leukaemic cells (L1210) by methotrexate and methotrexate plus citrovorum factor.

Authors:  A Goldin; J M Venditti; I Kline; N Mantel
Journal:  Nature       Date:  1966-12-31       Impact factor: 49.962

Review 3.  Methotrexate: clinical pharmacology, current status and therapeutic guidelines.

Authors:  W A Bleyer
Journal:  Cancer Treat Rev       Date:  1977-06       Impact factor: 12.111

4.  The clonal evolution of tumor cell populations.

Authors:  P C Nowell
Journal:  Science       Date:  1976-10-01       Impact factor: 47.728

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.